Molecular heterogeneity of TFE3 activation in renal cell carcinomas. (Q54341872)

28 May 2018

title

Molecular heterogeneity of TFE3 activation in renal cell carcinomas. (English)

1 reference

28 May 2018

1 reference

4

Markus Hohenfellner

1 reference

28 May 2018

author name string

Stephan Macher-Goeppinger

1

1 reference

28 May 2018

Wilfried Roth

2

1 reference

28 May 2018

Nina Wagener

3

1 reference

28 May 2018

Roland Penzel

5

1 reference

28 May 2018

Axel Haferkamp

6

1 reference

28 May 2018

Peter Schirmacher

7

1 reference

28 May 2018

Sebastian Aulmann

8

1 reference

28 May 2018

publication date

28 October 2011

1 reference

28 May 2018

published in

Modern Pathology

1 reference

28 May 2018

volume

25

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

308-315

1 reference

28 May 2018

Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Decoy receptor 3 is a prognostic factor in renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

Cytogenetics of a renal adenocarcinoma in a 2-year-old child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

7 January 2021

Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: possible Xp11.2 translocation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

7 January 2021

Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

7 January 2021

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.169

7 January 2021

10.1038/MODPATHOL.2011.169

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018